Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 43.

Bogowicz, M; Riesterer, O; Bundschuh, R A; Veit-Haibach, P; Hüllner, M; Studer, G; Stieb, S; Glatz, S; Pruschy, M; Guckenberger, M; Tanadini-Lang, S (2016). Stability of radiomic features in CT perfusion maps. Physics in Medicine and Biology, 61(24):8736-8749.

Oehler, C; Lang, S; Dimmerling, P; Bolesch, C; Klöck, S; Tini, A; Glanzmann, C; Najafi, Y; Studer, G; Zwahlen, D (2014). PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers. Radiation Oncology, 9:229.

Gander, T; Studer, S; Studer, G; Grätz, K W; Bredell, M (2014). Medium-term outcome of Astra Tech implants in head and neck oncology patients. International Journal of Oral and Maxillofacial Surgery, 43(11):1381-1385.

Studer, G; Stocker, D N; Loewenich, K F; Glanzmann, C (2014). 40/42 Gy in 13 fractions: a safe dose for the brachial plexus. Journal of Nuclear Medicine & Radiation Therapy, 5(168 ):online.

Janssen, S; Glanzmann, C; Bauernfeind, P; Stieb, S; Studer, G; Brown, M; Riesterer, O (2014). Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiation Oncology, 9:199.

Janssen, S; Glanzmann, C; Holzmann, D; Studer, G (2014). IMRT for nasal tumors - local control and cosmetic outcome. Journal of Nuclear Medicine & Radiation Therapy:5:170.

Janssen, S; Glanzmann, C; Huber, G; Studer, G (2014). Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary. Strahlentherapie und Onkologie, 190(4):386-393.

Holz-Sapra, E; Glanzmann, C; Schmid, S; Went, P; Studer, G (2014). Lymphoepithelial carcinoma of the salivary glands: case report of a rare cancer and review of the literature. Journal of Medical Research and Development, 3(4):184-192.

Wernhart, S; Woernle, C M; Neidert, M C; Bode, B; Rushing, E J; Studer, G; Fuchs, I; Regli, L; Sürücü, O (2013). A deeply seated brain metastasis from a primary myxofibrosarcoma: Case report. Clinical Neurology and Neurosurgery, 115(10):2296-2298.

Veit-Haibach, P; Schmid, D; Strobel, K; Soyka, J D; Schaefer, N G; Haerle, S K; Huber, G F; Studer, G; Seifert, Burkhardt; Hany, T F (2013). Combined PET/CT-perfusion in patients with head and neck cancers. European Radiology, 23(1):163-173.

Broglie, M A; Soltermann, A; Rohrbach, D; Haile, S R; Pawlita, M; Studer, G; Huber, G F; Moch, H; Stoeckli, S J (2013). Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head and Neck, 35(12):1698-1706.

Studer, G; Glanzmann, C; Bredell, M (2013). Kurative Bestrahlung von Kopf-Hals-Tumoren - Toleranzgewinn gegenüber früheren Techniken. info@onkologie, (5):7-11.

Studer, G; Glanzmann, C; Rordorf, T (2013). Kurative Radiochemotherapie von Pharynx-Tumoren. Heutiger Stand offener Forschungsfragen. info@onkologie, (5):11-14.

Studer, G; Linsenmeier, C; Riesterer, O; Najafi, Y; Brown, M; Yousefi, B; Bredell, M; Huber, G; Schmid, S; Studer, S; Zwahlen, R; Rordorf, T; Glanzmann, C (2013). Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiation Oncology, 8:259.

Ghadjar, P; Sun, H; Zimmermann, F; Bodis, S; Bernier, J; Studer, G; Aebersold, D M (2013). Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94). Oral Oncology, 49(10):1006-1009.

Studer, G; Glanzmann, C (2013). Volumetric stratification of cT4 stage head and neck cancer. Strahlentherapie und Onkologie, 189(10):867-873.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Ghadjar, P; Simcock, M; Studer, G; Allal, A; Ozsahin, M; Bernier, J; Töpfer, M; Zimmermann, F; Betz, M; Glanzmann, C; Aebersold, D (2012). Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). International Journal of Radiation Oncology, Biology and Physics, 82(2):524-531.

Ghadjar, P; Simcock, M; Zimmermann, F; Betz, M; Bodis, S; Bernier, J; Studer, G; Aebersold, M (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and Oncology, 104(2):213-218.

Studer, G; Bode, B; Fuchs, B (2012). Stellenwert der Radiothearpie. Extremitäten-Weichteil-Sarkom des Erwachsenen. info@onkologie, (2):14-17.

Studer, G; Bode-Lesniewska, B; Fuchs, B (2012). Stellenwert der Radiotherapie. info@onkologie, (2):14-17.

Studer, G (2012). Therapie des rezidivierten/ metastasierten Mammakarzinoms in "Zweitlinientherapie des Mammakarzinoms". In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen: Uni Med Science Verlag, 14-93.

Bredell, M; Rordorf, T; Studer, G (2012). Treatment concepts of oral cancer. Journal of the South African Dental Association (SADJ), 67(10):574-576.

Petrausch, U; Samaras, P; Mischo, A; Stenner, F; Tinguely, M; Schäfer, N; Studer, G; Renner, C (2011). Die Nachsorge beim Hodgkin-Lymphom. Praxis, 100(25):1515-1522.

Huber, G F; Zullig, L; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Studer, G; Jochum, W; Moch, H; Stoeckli, S J (2011). Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer, 11:217.

Peponi, E; Glanzmann, C; Willi, B; Huber, G; Studer, G (2011). Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiation Oncology, 6:1.

Studer, G; Brown, M; Salgueiro, E B; Schmückle, H; Romancuk, N; Winkler, G; Lee, S J; Sträuli, A; Kissling, B; Dummer, R; Glanzmann, C (2011). Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent Cetuximab and IMRT. International Journal of Radiation Oncology, Biology and Physics, 81(1):110-117.

Studer, G; Rordorf, T; Glanzmann, C (2011). Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer. Radiation Oncology, 6:120.

Studer, G; Glanzmann, C (2011). Increased recurrences using IMRT in the postoperative setting? American Journal of Clinical Oncology, 34(4):442.

Studer, G; Glanzmann, C; Studer, S P; Grätz, K W; Bredell, M; Locher, M C; Lütolf, U M; Zwahlen, R A (2011). Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT). Schweizer Monatsschrift für Zahnmedizin SMfZ, 121(3):216-229.

Studer, G; Peponi, E; Kloeck, S; Dossenbach, T; Huber, G; Glanzmann, C (2010). Surviving hypopharynx-larynx carcinoma in the era of IMRT. International Journal of Radiation Oncology, Biology and Physics, 77(5):1391-1396.

Broglie, M A; Huber, G F; Stöckli, S J; Studer, G (2010). Intensitätsmodulierte Radiotherapie beim Oropharynxkarzinom. In: 97. Frühjahresversammlung der SGORL, Zürich, Zürich, 17 June 2010 - 18 June 2010, S114-S116.

Peponi, E; Glanzmann, C; Kunz, G; Renner, C; Tomuschat, K; Studer, G (2010). Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) in nasopharyngeal cancer. Strahlentherapie und Onkologie:135-142.

Röösli, C; Tschudi, D C; Studer, G; Braun, J; Stoeckli, S J (2009). Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. Laryngoscope, 119(3):534-540.

Röösli, C; Studer, G; Stoeckli, S J (2009). Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head and Neck, 32(8):989-996.

Studer, G; Seifert, Burkhardt; Glanzmann, C (2008). Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging? Strahlentherapie und Onkologie, 184(11):580-585.

Zwahlen, R A; Dannemann, C; Grätz, K W; Studer, G; Zwahlen, D; Moergeli, H; Drabe, N; Büchi, S; Jenewein, J (2008). Quality of life and psychiatric morbidity in patients successfully treated for oral cavity squamous cell cancer and their wives. Journal of Oral and Maxillofacial Surgery, 66(6):1125-1132.

Studer, G; Glanzmann, C; Studer, S P; Grätz, K W; Lütolf, U M; Zwahlen, R A (2007). Empfehlung für die Zahnsanierung vor intensitätsmodulierter Radiotherapie (IMRT). UniversitätsSpital Zürich (USZ)-Richtlinien-Anpassung. Schweizer Monatsschrift für Zahnmedizin SMfZ, 117(6):637-647.

Oehler-Jänne, C; Seifert, Burkhardt; Lütolf, U M; Studer, G; Glanzmann, C; Ciernik, I F (2007). Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy, 6(3):218-226.

Studer, G; Zwahlen, R A; Grätz, K W; Davis, B J; Glanzmann, C (2007). IMRT in oral cavity cancer. Radiation Oncology, 2:16.

Studer, G; Huguenin, P U; Davis, J B; Kunz, G; Lütolf, U M; Glanzmann, C (2006). IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiation Oncology, 1:7.

Studer, G; Furrer, K; Davis, B J; Stoeckli, S S; Zwahlen, R A; Luetolf, U M; Glanzmann, C (2006). Postoperative IMRT in head and neck cancer. Radiation Oncology, 1:40.

Studer, G; Grätz, K W; Glanzmann, C (2004). Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlentherapie und Onkologie, 180(4):233-240.

This list was generated on Wed Sep 20 15:13:52 2017 CEST.